Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Thursday, 9th May 2024 AVXL stock ended at $3.88. This is 4.58% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.32% from a day low at $3.60 to a day high of $3.93.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Jan 03, 2017 $4.00 $4.12 $3.97 $4.11 455 404
Dec 30, 2016 $4.00 $4.05 $3.90 $3.96 465 526
Dec 29, 2016 $4.05 $4.12 $3.94 $3.99 338 628
Dec 28, 2016 $4.12 $4.14 $3.96 $4.05 502 650
Dec 27, 2016 $4.03 $4.22 $4.03 $4.14 559 380
Dec 23, 2016 $3.92 $4.14 $3.92 $4.09 452 844
Dec 22, 2016 $3.90 $4.02 $3.88 $4.00 422 848
Dec 21, 2016 $4.10 $4.12 $3.90 $3.91 825 265
Dec 20, 2016 $4.20 $4.27 $4.05 $4.09 544 900
Dec 19, 2016 $4.05 $4.22 $4.01 $4.20 601 754
Dec 16, 2016 $4.07 $4.24 $3.98 $4.08 716 168
Dec 15, 2016 $4.22 $4.22 $3.95 $4.09 813 981
Dec 14, 2016 $4.20 $4.34 $3.89 $4.24 1 289 083
Dec 13, 2016 $4.80 $4.85 $4.16 $4.23 2 201 329
Dec 12, 2016 $4.65 $4.88 $4.43 $4.88 2 397 034
Dec 09, 2016 $4.27 $4.47 $4.03 $4.35 2 533 202
Dec 08, 2016 $4.10 $4.23 $3.80 $4.23 2 541 498
Dec 07, 2016 $3.78 $3.82 $3.52 $3.73 764 465
Dec 06, 2016 $3.79 $3.85 $3.70 $3.83 409 554
Dec 05, 2016 $3.90 $3.90 $3.69 $3.80 399 719
Dec 02, 2016 $3.78 $3.90 $3.69 $3.76 558 041
Dec 01, 2016 $3.97 $4.00 $3.70 $3.81 789 894
Nov 30, 2016 $4.00 $4.08 $3.81 $3.97 672 810
Nov 29, 2016 $4.13 $4.19 $3.90 $4.00 1 087 985
Nov 28, 2016 $4.00 $4.28 $3.85 $4.13 2 815 009
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT